Loading resource…

MULINZI SOLOMON
This document provides a comprehensive overview of pulmonary hypertension (PH), beginning with its definition and historical hemodynamic thresholds, noting the proposed shift in the 6th World Symposium on Pulmonary Hypertension. It delves into the epidemiology, highlighting the difficulty in determining prevalence due to disease heterogeneity and underdiagnosis, and lists various risk factors and associated conditions. The pathophysiology section explains the primary mechanism of increased pulmonary vascular resistance, involving vasoconstriction, remodeling, and thrombosis, linked to endothelial dysfunction. Diagnostic advances are discussed, including non-invasive screening tools like echocardiograms and laboratory tests, alongside imaging and pulmonary function tests, with right heart catheterization identified as the gold standard.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

HEART FAILURE AND CARDIAC ARRHYTHMIAS
Same clinical topic · Cardiology

HEART FAILURE AND IT’S MANAGEMENT
Same clinical topic · Cardiology

CORONARY HEART DISEASE
Same clinical topic · Cardiology

UNDERSTANDING PREVENTION AND MANAGEMENT OF ISCHAEMIC HEART DISEASE FOR ALL IN UGANDA
Same clinical topic · Cardiology

HYPERTENSION UPDATES 2025 NEBIVOLOL
Same clinical topic · Cardiology

HEART-FAILURE-AND-IT-S-MANAGEMENT-1-
Same clinical topic · Cardiology

anthypertensive pharmacology
Same clinical topic · Cardiology

heart failure-Oreb
Same clinical topic · Cardiology

RHEUMATIC HEART DISEASE AND INFECTIVE ENDOCARDITIS
Same clinical topic · Cardiology